launched July 1, 2026 through December 31, 2027 Who Faces the Greatest Need for This Coverage The groups most likely to benefit from the Medicare GLP-1 Bridge program include: Medicare Part D enrollees ages 65 and older with a body mass index of 35 or higher, or a BMI of 27 or higher combined with a qualifying condition such as cardiovascular disease or prediabetes Adults with obesity who were previously unable to afford brand-name GLP-1 medications on fixed retirement incomes People who discontinued brand-name GLP-1 treatment due to cost and are eligible to re-enter with the $50 Bridge copay Patients managing obesity-related conditions including hypertension, sleep apnea, and prediabetes, who may reduce downstream healthcare costs through weight management People who already receive GLP-1 coverage through their Part D plan for diabetes, cardiovascular disease, or sleep apnea do not qualify for the Bridge program they continue to access the drugs through their existing coverage

You may need more than one session once a month depending on your skin type and requirement
He said: Research has shown that by choosing foods correctly, you will boost your GLP-1 naturally without an injection. Other experts said the drugs would have a limited impact if patients continued to eat lots of foods high in sugar and fat
Rotate injection sites regularly to prevent lipodystrophy and scarring that can affect absorption
The benzyl alcohol preservative inhibits bacterial growth across multiple needle punctures, which is why BAC water outperforms sterile water for any multi-dose preparation